FindTrial
Sign In

Characteristics, prognosis, and treatments effectiveness of critically ill patients with Novel Coronavirus Pneumonia (COVID-19)

Characteristics, prognosis, and treatments effectiveness of critically ill patients with Novel Coronavirus Pneumonia (COVID-19): a dual-center, retrospective, cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030742
Enrollment
Unknown
Registered
2020-03-13
Start date
2020-03-15
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel coronavirus pneumonia (COVID-19)

Interventions

Case series:no

Sponsors

Tongji Hospital, Tongji Medical College,Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. confirmed with COVID-19; 2. ICU admission; 3. meet the critically ill criteria according to Chinese management guideline for COVID-19 (version 7)

Exclusion criteria

Exclusion criteria: 1. younger than 18 years old; 2. do not fulfill the criteria of critical cases; 3. declared clinical death or discharged after ICU admission within 24 hour; 4. important data missing.

Design outcomes

Primary

MeasureTime frame
in-ICU mortality;—

Countries

China

Contacts

Public ContactHongyu Gao

Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

hygao@tjh.tjmu.edu.cn+86 13886188018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026